Topics

Pfizer's heart drug impresses with fast US launch

07:19 EDT 29 Oct 2019 | BioPharmaDive

Though overall sales in the third quarter fell compared to the same period a year ago, the pharma's core drugs business grew by about 7%.

Original Article: Pfizer's heart drug impresses with fast US launch

NEXT ARTICLE

More From BioPortfolio on "Pfizer's heart drug impresses with fast US launch"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...